Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Wakely
Digital Health
Omada GLP-1 program to prioritize muscle mass restoration
Omada will connect customers with a care team and physical therapists to help patients regain muscle mass after stopping GLP-1 drug usage.
Noah Tong
Feb 13, 2024 9:00am
AHIP: New Medicare benefits may increase MA costs
Aug 24, 2021 11:19am
Diagnostic testing costs up to $25B, antibody tests $19B: study
Jun 10, 2020 12:06pm
COVID-19 could cost insurers up to $547B through 2021: report
Jun 8, 2020 12:30pm
Industry Voices—Ensuring premium revenue accuracy during COVID
May 11, 2020 3:25pm
Insurers press CMS for more money to treat ESRD patients in MA
Mar 9, 2020 4:33pm
